STREPSILS LIDOCAINE, lozenge 36 lozenges
Active ingredients: Dichlorobenzyl alcohol, AMYLMÉTACRÉSOL, Lidocaine hydrochloride
Commercialized according to BDPM
Lozenge36 lozengesvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- STREPSILS LIDOCAINE, pastille
- Pharmaceutical form
- pastille
- Route of administration
- voie buccale autre
- Presentation description
- plaquette(s) PVC-Aluminium PVDC de 36 pastille(s)
- Marketing authorisation holder
- RECKITT BENCKISER HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Nov 2020
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68139273CIP73851371CIP133400938513714Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMYLMÉTACRÉSOLpastille | 0,60 mg · une pastille | SA |
| ALCOOL DICHLORO-2,4 BENZYLIQUEpastille | 1,20 mg · une pastille | SA |
| CHLORHYDRATE DE LIDOCAÏNEpastille | 2 mg · une pastille | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.